The United States and European markets could suffer from the debt crisis following the 2008 global financial crisis, and more governments worldwide are enacting healthcare reform to reduce budget deficits. As a result, new products for minimally invasive procedures will drive the market in the future.
The report predicts more favorable reimbursement for minimally invasive procedures due to the reduced hospital stay. With time, the market could see further consolidation. Key companies in the orthopedics market include Johnson & Johnson, Stryker, Zimmer and Smith & Nephew.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Devices:
ArthroCare Revenues Down in 2011
Synthes Earnings Grow as Johnson & Johnson Acquisition Closing Nears
DJO Global Reports Slight Increase in 4Q Surgical Implant Sales
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
